What’s been happening:

Since graduating from PSU, I have been involved in a number of endeavors. Following my fellowship in Pediatric Cardiology, I spent 10 years on the staff of Cincinnati Children's Hospital. I also headed up an NIH-funded laboratory looking into various aspects of cardiac metabolism as related to disease processes involving the heart. I joined Bristol-Myers-Squibb Company in 1988. My responsibilities included directing clinical trials with their (then) new cholesterol-lowing drug Pravachol. I also oversaw promotional material development to insure that claims were backed by study data. Following reorganization, I was transferred to oncology/immunology division's of regulatory affairs. I reviewed advertising materials for compliance with FDA regulations, and was involved when product labeling changes were being prepared for FDA submission. I interacted daily with FDA to negotiate acceptable materials and/or labeling. In 1999 I decided to accept position as Executive Director Drug Safety, North America for a contract research organization. My large staff was responsible for reporting drug side effects to sponsor companies and FDA within legally-defined time frames. Wanting more patient interaction, I moved back to Cincinnati to became Medical Director of a lipid-disorder practice which did clinical trials. I recruited patients and directed drug company studies in cholesterol-lowering, high blood pressure, diabetes, weight-loss, etc. Subsequently, I have retired and keep busy with drug consulting, volunteer work, playing golf, hobbies, and traveling.